• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)

    0.6660 +0.0189 (+2.92%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Liminatus Pharma, Inc. - Class A Common Stock

    News headline image
    Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
    From Liminatus Pharma Inc.
    Via GlobeNewswire
    News headline image
    Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
    Liminatus Identifies BNB Coin as Its Primary Strategic Target for Digital Asset Allocation, with Plans to Aggressively Accumulate and Hold Up to $500 Million for Long-Term Strategic Value 
    From Liminatus Pharma Inc.
    Via GlobeNewswire
    News headline image
    Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies
    Strategic Internal Review initiated for treasury diversification through a prospective digital asset subsidiary — no entity formed, no capital committed 
    From Liminatus Pharma Inc.
    Via GlobeNewswire
    News headline image
    Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
    Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing paths 
    From Liminatus Pharma Inc.
    Via GlobeNewswire
    News headline image
    Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
    Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficiency while maintaining core focus on immunotherapy innovation 
    From Liminatus Pharma Inc.
    Via GlobeNewswire
    News headline image
    Power Metallic (TSX.V: PNPN) (OTCQB: PNPNF) Strikes Big at Lion Zone – Major Discovery Near Nisk Ignites Investor Buzz – More Stocks Inside
    Via AB Newswire
    Topics Economy
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.